Agios Pharmaceuticals
AGIO
AGIO
143 hedge funds and large institutions have $1.46B invested in Agios Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 56 increasing their positions, 46 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $1.68B → $1.46B (-$217M)
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
48% less call options, than puts
Call options by funds: $6.15M | Put options by funds: $11.9M
Holders
143
Holding in Top 10
1
Calls
$6.15M
Puts
$11.9M
Top Buyers
| 1 | +$10.5M | |
| 2 | +$9.04M | |
| 3 | +$8.23M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$7.23M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.98M |
Top Sellers
| 1 | -$16.5M | |
| 2 | -$9.54M | |
| 3 | -$7.86M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$5.03M |
| 5 |
Man Group
London,
United Kingdom
|
-$4.83M |